drugset / Trial / NCT05923268
Molecular Imaging of HER2 Expression in Breast Cancer Using [99mTc]Tc-G3-(G3S)3C Before Chemo/Targeted Therapy
NaSingle-groupOpen-labelDiagnostic
Summary
The study should evaluate distribution of \[99mTc\]Tc-G3-(G3S)3C in patients with primary HER2-positive and HER2-negative breast cancer
Timeline
- Start
- 2023-06-04
- Primary completion
- 2024-06-15
- Completion
- 2024-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [99mTc]Tc-G3-(G3S)3C | Protein / enzyme biologic | 3000 ug | — |